Buy Loxicom 20mg/mL Solution for Injection Online: The Definitive Veterinary Guide to Advanced Meloxicam NSAID Therapy, Oxicam Pharmacology, and Livestock Management

In commercial livestock husbandry, swine production, and equine medicine, managing acute inflammation, severe pain, and high systemic fevers is a fundamental clinical necessity. Conditions such as Bovine Respiratory Disease (BRD), acute mastitis, Porcine Metritis-Mastitis-Agalactia (MMA) syndrome, and severe musculoskeletal lameness trigger a dramatic release of destructive cellular enzymes. These pathways cause ongoing tissue injury, lower daily feed intake, impair milk yield, and compromise overall animal welfare.

Traditional corticosteroid treatments reduce swelling effectively but can suppress the animal’s immune response, making them risky during active bacterial infections.

To safely disrupt the inflammatory cascade without compromising immune defenses, veterinarians rely on target-specific Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). Loxicom 20mg/mL Solution for Injection (manufactured by Norbrook Laboratories) is a premier veterinary NSAID. Delivering a highly bioavailable 20mg/mL dose of Meloxicam, this sterile formulation selectively targets inflammatory pathways. It provides rapid relief from pain, reduces localized swelling, lowers high fevers, and helps sick animals return to normal feeding patterns quickly.

This comprehensive clinical reference manual details the molecular pharmacology, target cellular pathways, veterinary applications, and precise on-farm dosing protocols for Loxicom 20mg/mL.

1. Molecular Pharmacology & Mechanism of Action

Meloxicam belongs to the oxicam class of NSAIDs and acts as a potent, reversible inhibitor of cyclooxygenase enzymes:

                          [Loxicom 20mg/mL Injection Administered]
                                             |
                         [Rapid Systemic Vascular Bioavailability]
                                             |
                         [Targeting of Inflamed Tissue Networks]
                                             |
                 -------------------------------------------------
                |                                                 |
       [COX-1 PATHWAY]                                   [COX-2 PATHWAY]
      (Constitutive/Good)                             (Inducible/Inflammatory)
                |                                                 |
      (Minimal Interaction)                          (Highly Selective Inhibition)
                |                                                 |
                v                                                 v
    [Preserves Stomach Lining]                      [Blocks Prostaglandin E2 (PGE2)]
    [Maintains Renal Blood Flow]                     [Halts Localized Pain Signaling]
                |                                                 |
                 ------------------------> <----------------------
                                        |
                                        v
                    [Rapid Reduction of Swelling, Heat, and Fever]
                                        |
                    [Restored Animal Appetite and Production Yields]

Selective Cyclooxygenase-2 (COX-2) Inhibition

Tissue injury or bacterial infection causes cellular membranes to release arachidonic acid, which is converted into inflammatory signals by cyclooxygenase (COX) enzymes. Loxicom works by preferentially binding to the COX-2 (cyclooxygenase-2) enzyme pathway:

• Halting Prostaglandins: This selective binding prevents the production of Prostaglandin E2 (PGE2), the main chemical messenger responsible for triggering local swelling, pain transmission, and fever in the brain.

• The COX-1 Safety Advantage: Because Loxicom avoids significant interaction with the baseline COX-1 pathway, it preserves the vital prostaglandins needed to protect the stomach lining and maintain healthy blood flow to the kidneys.

Anti-Endotoxic Properties

In severe conditions like acute mastitis or MMA syndrome, dying bacteria release harmful endotoxins into the bloodstream, which can cause cardiovascular shock. Meloxicam has been clinically proven to suppress these endotoxin-induced pathways, stabilizing the animal’s circulation and protecting vital organ systems.

2. Core Veterinary Clinical Applications

Loxicom 20mg/mL is an essential therapeutic tool across major large-animal and livestock sectors:

Bovine / Cattle Medicine

• Acute Respiratory Infections (BRD): Paired with appropriate broad-spectrum antibiotic therapy (such as Hemoflor Plus) to reduce lung swelling and restore normal breathing.

• Severe Acute Mastitis: Reduces localized udder swelling, lowers high fevers, and protects milk-producing tissues from permanent damage.

• Diarrhea Management: Administered to calves over one week of age to reduce visceral pain and improve survival rates during severe scours.

Porcine / Swine Production

• Locomotor Disorders: Reduces lameness and joint inflammation in growing pigs.

• MMA Syndrome Treatment: Administered to post-parturient sows to lower fevers and ease pain, helping them resume nursing and preventing piglet starvation.

Equine / Horse Sports Medicine

• Musculoskeletal Relief: Alleviates acute pain and swelling associated with joint inflammation, strains, sprains, and chronic osteoarthritis.

• Equine Colic Management: Used under strict veterinary guidance to reduce visceral abdominal pain and lower inflammation within the intestinal wall.

3. Recommended Administration and Livestock Dosing Protocols

To ensure patient safety and maximize therapeutic efficacy, Loxicom 20mg/mL must be administered following precise veterinary guidelines.

Veterinary Dosing Reference Table

The table below outlines standard clinical dosing protocols for Loxicom 20mg/mL:

4. Clinical Safety, Contraindications, and Withdrawal Periods

• Dehydration Warning: Avoid administering NSAIDs to animals suffering from severe dehydration, shock, or low blood pressure, as this can increase the risk of kidney strain. Ensure treated animals have constant access to fresh water.

• Avoid Mixing Solutions: Do not combine Loxicom within the same syringe as other medications or fluids to prevent chemical incompatibility or precipitation.

• Gastric Ulcer Caution: Do not use in animals suffering from active gastrointestinal ulcers or known bleeding disorders.

Agricultural Food Safety Withdrawal Windows

To prevent drug residues from entering the human food chain, adhere strictly to these withdrawal times:

5. Frequently Asked Questions (FAQ)

Can Loxicom 20mg/mL be given intramuscularly (IM) to cattle?

No. Loxicom 20mg/mL is approved for subcutaneous (SC) or intravenous (IV) injection only in cattle. Injecting it intramuscularly can cause localized tissue irritation and alter how the drug is absorbed.

How quickly does Loxicom work to reduce fever?

Meloxicam is highly bioavailable, typically reaching peak plasma concentrations within 1 to 3 hours of injection. A visible drop in fever, along with improved alertness and appetite, is routinely observed within this window.

Can this injection be used in pregnant animals?

Loxicom 20mg/mL is safe for use in pregnant and lactating beef cattle and swine. However, do not use it in mares during their final trimester of pregnancy or in breeding horses, as safety has not been fully evaluated for those classes.

Where can I buy genuine Loxicom 20 mg/mL online?

You can safely purchase authentic, factory-sealed Loxicom 20mg/mL Solution for Injection online through Pet Well Global. Every batch is stored within our climate-controlled pharmaceutical facility to guarantee absolute stability and full therapeutic potency.

6. Secure Pharmaceutical Distribution from Pet Well Global

At Pet Well Global, we are dedicated to providing livestock managers, performance operations, and veterinary practitioners with authentic, high-grade pharmaceuticals. Every container of Loxicom 20mg/mL is stored under strict temperature controls between 15°C and 25°C and shipped securely to maintain sterile product value.

LOXICOM 20MG/ML for Cattle: For use in acute respiratory infection with appropriate
antibiotic therapy to reduce clinical signs in cattle. For use in.

LOXICOM 20MG/ML  for Cattle: For use in acute respiratory infection with appropriate
antibiotic therapy to reduce clinical signs in cattle. For use in
diarrhoea in combination with oral re-hydration therapy to
reduce clinical signs in calves of over one week of age and
young, non-lactating cattle.
For adjunctive therapy in the treatment of acute mastitis, in
combination with antibiotic therapy.

Pigs: For use in non-infectious locomotor disorders to reduce
the symptoms of lameness and inflammation.
For adjunctive therapy in the treatment of puerperal
septicaemia and toxaemia (mastitis-metritis-agalactia
syndrome) with appropriate antibiotic therapy.

Horses: For use in the alleviation of inflammation and relief of
pain in both acute and chronic musculo-skeletal disorders. For
the relief of pain associated with equine colic.

Dosage & Administration of

Cattle: Single subcutaneous or intravenous injection at a
dosage of 0.5 mg meloxicam/kg body weight (i.e., 2.5 ml/100
kg body weight) in combination with antibiotic therapy or
with oral re-hydration therapy, as appropriate. The
recommended maximum volume to be administered at a
single injection site is 10 ml.

Pigs: Single intramuscular injection at a dosage of 0.4 mg
meloxicam/ kg body weight (i.e., 2.0 ml/100 kg body weight)
in combination with antibiotic therapy, as appropriate. If
required, a second administration of meloxicam can be given
after 24 hours. The recommended maximum volume to be
administered at a single injection site is 2 ml.

Horses: Single intravenous injection as a dosage of 0.6 mg
meloxicam/kg body weight (i.e., 3.0 ml/100 kg body weight).
For use in the alleviation of inflammation and the relief of pain
in both acute and chronic musculoskeletal disorders. A
suitable oral therapy containing meloxicam, administered in
accordance with label recommendations, may be used for
continuation of treatment.
Avoid introduction of contamination during use.
Do not exceed 50 broachings per vial. If more than 50
broachings
are required, the use of a draw-off needle is recommended.

Withdrawal Period for LOXICOM 20MG/ML

Cattle: Meat and offal: 15 days Milk: 5 days
Pigs: Meat and offal: 5 days
Horses: Meat and offal: 5 days.
Not authorised for use in horses producing milk for human
consumption.

Contraindictions, Warnings etc for LOXICOM 20MG/ML

Do not use in horses less than 6 weeks of age. Do not use in
pregnant or lactating mares. Do not use in animals suffering
from impaired hepatic, cardiac or renal function and
haemorrhagic disorders, or where there is evidence of
ulcerogenic gastrointestinal lesions.
Do not use in case of hypersensitivity to the active substance
or to any of the excipients.
For the treatment of diarrhoea in cattle, do not use in animals
of less than one week of age.
If adverse reactions occur, treatment should be discontinued
and the advice of a veterinarian should be sought. Avoid use
in very severely dehydrated, hypovolaemic or hypotensive
animals which require parenteral rehydration, as there may be
a potential risk of renal toxicity.
In case of inadequate relief of pain when used in the
treatment of equine colic, careful re-evaluation of the
diagnosis should be made as this could indicate the need for
surgical intervention. LOXICOM 20MG/ML LOXICOM 20MG/ML
Accidental self-injection may give rise to pain. People with
known hypersensitivity to Non-Steroidal Anti-Inflammatory
Drugs (NSAIDs) should avoid contact with the veterinary
medicinal product.
In case of accidental self-injection, seek medical advice
immediately and show this package leaflet or the label to the
physician. LOXICOM 20MG/ML LOXICOM 20MG/ML LOXICOM 20MG/ML LOXICOM 20MG/ML